MedPath

Islet transplant into the skin - a novel treatment for type 1 diabetes using organ donor islets and an integrated scaffold.

Not Applicable
Recruiting
Conditions
Type 1 diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12621001573842
Lead Sponsor
Royal Adelaide Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

Patients with Type 1 Diabetes Mellitus who are recipients of a functional renal allograft (glomerular filtration rate of >40 ml/min) and taking immunosuppressant medication following that allograft.

Exclusion Criteria

Pregnancy/Lactation
Active infection or malignancy (other than locally controlled squamous cell carcinoma or basal cell carcinoma)
Non-English speakers (from an informed consent perspective), unless an information and consent form in the subject’s language is available along with a study coordinator capable of answering questions in that language.
Known allergy/previous reaction to polyurethane dressing materials
Unwillingness to consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath